Autoimmune Encephalitides: A Broadening Field of Treatable Conditions
Neurologist 22:1-13, Kalman, B., 2017
Combination Antifungal Therapy for Cryptococcal Meningitis
NEJM 368:1291-1302, Day, J.,et al, 2013
Brain Biopsy in Patients with Acquired Immunodeficiency Syndrome, Diagnostic Value, Clinical Performance, and Survival Time
Arch Int Med 159:2590-2596, Hornef,M.W.,et al, 1999
Recommendations for the Management of Cerebral and Cerebellar Infarction with Swelling
Stroke 45:1222-1238, Wijdicks, E.F.M.,et al, 2014
Predictors of Neurologic Outcome in Hypothermia After Cardiac Arrest
Ann Neurol 68:907-914, Fugate,J.E.,et al, 2010
Variability of Brain Death Determination Guidelines in Leading US Neurologic Institutions
Neurol 70:284-289,252, Greer,D.M.,et al, 2008
Evaluation and Management of Intracranial Mass Lesions in AIDS
Rpt of Quality Stnds Subcomm of the AAN, Neurol 50:21-261998., , 1998
Determining Brain Death in Adults
Neurol 45:1003-1011, Wijdicks,E.F.M., 1995
Variability in Brain Death Determination Practices in Children
JAMA 274:550-553, Mejia,R.E.&Pollack,M.M., 1995
Guidelines on the Detection of Paraneoplastic Anti-Neuronal-Specific Antibodies
Neurol 45:1937-1941, Moll,J.W.B.,et al, 1995
Concussion in Sports, Guidelines for the Prevention of Catastrophic Outcome
JAMA 266:2867-2869, Kelly,J.P.,et al, 1991
Diagnosis and Management of Cerebral Venous Thrombosis:A Scientific Statement From the American Heart Association
Stroke 55:e77-e90, Saposnik,G.,et al, 2024
Pediatric and Adult Brain Death/Death by Neurologic Criteria Consensus Guidelines
Neurol 101:1112-1132, Greer,D.M.,et al, 2023
Determination of Brain Death
NEJM 385:2554-2561, Greer, D.M., 2021
Determination of Brain Death/Death by Neurologic Criteria
JAMA doi:10.1001/JAMA.2020.11586, Greer, D.M.,et al, 2020
Brain Death, the Determination of Brain Death, and Member Guidance for Brain Death Accommodation Requests
Neurol 92:228-232, Russell, J.A.,et al, 2019
Management of Stroke in Neonates and Children
Stroke 50:e51-e96, Ferriero, D.M.,et al, 2019
End of Life
Neurol 93:729-734, Masdeu, J.C.,et al, 2019
Lawful Physician-Hastened Death
Neurol 90:420-422, Russell, J.A.,et al, 2018
Subarachnoid Hemorrhage
NEJM 377:257-266, Lawton, M.T. & Vates, G.E., 2017
Migraine
NEJM 377:553-561, Charles, A., 2017
Anal Carcinoma
NCCN.org April 2017 V2.2017, , 2017
Myasthenia Gravis
NEJM 375:2570-2581, Gilhus, N.E.,et al, 2016
Brain Death Declaration
Neurol 84:1870-1879, Wahlster, S.,et al, 2015
Factor Xa Inhibitors vs Warfarin for Preventing Stroke and Thromboembolism in Patients with Atrial Fibrillation
JAMA 311:1150-1151, Bruins Slot, K.M.H. & Berge, E., 2014
Opt-Out HIV Testing in Adult Critical Care Units
Lancet 383:1460, Thornhill, J.,et al, 2014
Palliative and End-Of-Life Care in Stroke
Stroke 45:1887-1916, Holloway, R.G.,et al, 2014
Giant-Cell Arteritis and Polymyalgia Rheumatica
NEJM 371:50-57, Weyand, C.M. & Goronzy J.J., 2014
HIV Testing and Management of Newly Diagnosed HIV
BMJ 349:g4275, Rayment, M.,et al, 2014
Misdiagnosis of Treatable Stroke Mimic: The Case for HIV Screening in Practice Guidelines
Neurohosp 3:125-130, Finelli, P.F., 2013
Evidence-based Guideline: Antiepileptic Drug Selection for People with HIV/AIDS
Neurol 78:139-145, Birbeck,G.L.,et al, 2012
Evidence-based Guideline Update: NSAIDs and Other Complementary Treatments for Episodic Migraine Prevention in Adults
Neurol 78:1346-1353, Holland,S.,et al, 2012
Guidelines for the Determination of Brain Death in Infants and Children: An Update of the 1987 Task Force Recommendations - Executive Summary
Ann Neurol 71:573-585, Nakagawa,T.A.,et al, 2012
Hyperosmolar Therapy for Raised Intracranial Pressure
NEJM 367:746-752, Ropper, A.H., 2012
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Stroke 42:227-276, Furie,K.L.,et al, 2011
Diagnosis and Management of Cerebral Venous Thrombosis: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Stroke 42:1158-1192, Saposnik,G.,et al, 2011
Optic Neuritis: Prognosis and Treatment
UpToDate, Jan, Osborne, B.,et al, 2011
An Update on Brain Death Criteria A Simple Algorithm with Complex Questions
The Neurologist 17-237-240, Scripko, P.D.,et al, 2011
Evidence-based Guideline: Clinical Evaluation and Treatment of Transverse Myelitis
Neurol 77:2128-2134, Scott, T.F.,et al, 2011
Prognostication After Cardiac Arrest and Hypothermia: A Prospective Study
Ann Neurol 67:301-307, 5, Rossetti,A.O., et al, 2010
Natalizumab and Progressive Multifocal Leukoencephalopathy: What are the Causal Factors and Can It be Avoided?
Arch Neurol 67:923-930, Warnke,C., et al, 2010
Evidence-Based Guideline Update: Determining Brain Death in Adults: Report of the Quality Standards Subcommittee of the American Academy of Neurology
Neurol 74:1911-1918, Wijdicks,E.F.M., et al, 2010
Pregnancy and Fetal Outcomes After Interferon-b Exposure in Multiple Sclerosis
Neurol 75:1794-1802, Amato,M.P.,et al, 2010
Multiple Ring-Enhancing Lesions of the Brain
J Postgrad Med 56:307-316, Garg, R.K. & Sinha, M.K., 2010
Genetic Aspects of Alzheimer Disease
The Neurologist 15:80-86, Williamson,J.,et al, 2009
Intracerebral Haemorrhage
Lancet 373:1632-1644, Qureshi,A.I.,et al, 2009
Best Practice Recommendations for the Selection and Management of Patients with Multiple Sclerosis Receiving Natalizumab Therapy
Mutliple Sclerosis 15:S26-S36, Coyle,P.K.,et al, 2009
Management of Stroke in Infants and Children: A Scientific Statement From a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young
Stroke 39:2644-2691, Roach,E.S.,et al., 2008
Neutralizing Antibodies to Interferon Beta: Assessment of Their Clinical and Radiographic Impact: An Evidence Report
Neurol 68:977-984, Goodin,D.S.,et al, 2007